PharmaGroup ApS: Financial statements 2023
CVR: 43324667
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PharmaGroup ApS (CVR 43324667) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 8,771,950 and a net result of DKK 5,447,761 compared with DKK 1,017,604 the year before. That is an increase of 194.7% compared with the year before. Equity in the 2023 report amounted to DKK 7,254,388. The solvency ratio was 71.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 8,771,950
- Profit/Loss
- DKK 5,447,761
- Equity
- DKK 7,254,388
- Total Assets
- DKK 10,154,949
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PharmaGroup ApS has published its annual report for 2022. Gross profit came to DKK 2,976,522, and the net result was DKK 1,017,604.
About PharmaGroup ApS
PharmaGroup ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2022. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Amar Fakhry Alaa Al Dyen-Ahmad. The company is owned by PharmaGroup Holding ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 5,561,227 and a net result of DKK 2,366,747 compared with DKK 5,037,144 the year before. Equity in the 2025 report amounted to DKK 2,458,279.